| Accession |
PRJCA015046 |
| Title |
Determinants of the efficacy of neoadjuvant anti-PD-1-based therapy in esophageal squamous cell carcinoma |
| Relevance |
Medical |
| Data types |
Whole genome sequencing
Single cell sequencing
|
| Organisms |
Homo sapiens
|
| Description |
Genomic and immune determinants of the efficacy of neoadjuvant anti-PD-1-based therapy in esophageal squamous cell carcinoma |
| Sample scope |
Single cell |
| Release date |
2023-02-21 |
| Publication |
| PubMed ID |
Article title |
Journal name |
DOI |
Year |
| 38244291
|
Genomic profiling and associated B cell lineages delineate the efficacy of neoadjuvant anti-PD-1-based therapy in oesophageal squamous cell carcinoma
|
eBioMedicine
|
10.1016/j.ebiom.2024.104971
|
2024
|
|
|
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| Science and Technology Commission of Shanghai Municipality
|
General Program
|
22ZR1410700
|
|
|
|
| Submitter |
Di
Ge (ge.di@zs-hospital.sh.cn)
|
| Organization |
Zhongshan Hospital, Fudan University |
| Submission date |
2023-02-18 |
